Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Artesunate Suppositories

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT03100045Phase 1CompletedPrimary

Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)

Showing all 1 trials

Research Network

Common Treatments

  • Artesunate Suppositories1

Active Sponsors

  • Frantz Viral Therapeutics, LLC1
  • Johns Hopkins University1
  • University of Wisconsin, Madison1

Top Investigators

Related Conditions

  • Ain231
  • Artesunate1
  • Human Papilloma Virus1
  • Alternative Treatment1
  • Precancerous Conditions1

Activity Timeline